CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Foreign Currency Transaction Gain (Loss), before Tax
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Foreign Currency Transaction Gain (Loss), before Tax of $136.00 thousand for the 12-month period ending 2013-12-28, per its 10-K filed 2014-02-25.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2014-02-25
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. foreign currency transaction gain (loss), before tax for fiscal 2013 was $136.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. foreign currency transaction gain (loss), before tax for fiscal 2012 was -$892.00K, a 114.30% decline from fiscal 2011.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. foreign currency transaction gain (loss), before tax for fiscal 2011 was $6.24M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. foreign currency transaction gain (loss), before tax for fiscal 2010 was -$1.30M.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|
| 2013-12-28 | $136.00K 10-K · filed 2014-02-25 |
| 2012-12-29 | -$892.00K 10-K · filed 2014-02-25 |
| 2011-12-31 | $6.24M 10-K · filed 2014-02-25 |
| 2010-12-25 | -$1.30M 10-K · filed 2013-02-27 |
| 2009-12-26 | -$861.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |